WENA: anewmeds.com Company Cash on Hand

Brandmark of Anew Medical (WENA)

The cash history of Anew Medical, Inc. (WENA) demonstrates the development of a gene therapy ecosystem based on the Klotho protein, where the current amount is 0.00. The business's financial stability depends on the outcomes of scientific research in the absence of operating revenues. Currently, the strategy relies on the organic recovery of neurodegeneration treatment programs and licensing agreements with universities without new acquisitions.

WENA - Anew Medical Company Liquid Assets over the range 06/25/2024 - 09/17/2024

Metric breakdowns and analytics for Anew Medical, Inc. (WENA)

- stock value and consensus price forecast:
Basic company analysis:Anew Medical Inc. WENA
Brand item of Anew Medical Inc.

This metric aggregates total cash and equivalents on the issuer's accounts, determining its real-time solvency. Liquidity analysis allows for an assessment of the business's margin of safety and the risk of capital shortages. The trend of cash on the balance sheet reveals the rate of reserve depletion. For Anew Medical, Inc. (WENA), this is critical, as the development of gene therapy requires colossal expenditures prior to the commercialization stage. Monitoring balances prevents investing in a "value trap."

Competitors of Anew Medical, Inc.

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|ALZN (Alzamend Neuro) - Company Cash on Hand|Company Cash and Cash Equivalents CYCN|PTIX (Protagenic Therapeutics, Inc.) - Company Cash Volume|KTTA: Company Cash Balance|Company Cash Funds Cortigent Medical (CRGT)|ATXI - Company Cash Reserve|Company Cash Volume BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Cash Reserve|CHRO: Company Cash on Hand|Eliem Therapeutics Inc. (ELYM) - Company Cash on Hand|Intra-Cellular Therapies Inc. (ITCI) - Company Cash Funds|Company Total Cash Volume LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Company Cash Volume|Company Cash and Cash Equivalents NKGN (NKGen Biotech Inc)|Company Cash Volume NRBO|Company Cash on Hand Sage Therapeutics Inc SAGE|Company Cash Funds Synaptogenix SNPX|TRVN: Company Cash and Cash Equivalents|VIGL - Company Cash Funds|Company Liquid Assets Cerevel Therapeutics, Inc. CERE